- Published at
- by gurufocus.com
positive
positive
Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes
Tegoprubart to be Used as Immunosuppressive Agent in Cohort C of Sernova's Phase 1/2 Cell Pouch Bio-hybrid Organ Clinical Trial in Patients with Type 1 Diabete